This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
A Jemal , R Siegel , J Xu , et al. (2010) Cancer statistics. CA Cancer J Clin
2 EL Escobar , MC Gomes-Marcondes & HF Carvalho (2009) Dietary fatty acid quality affects AR and PPARgamma levels and prostate growth. Prostate 69, 548–558.
3 MD Brown , C Hart , E Gazi , et al. (2010) Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer. Br J Cancer 102, 403–413.
4 IM Berquin , Y Min , R Wu , et al. (2007) Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest 117, 1866–1875.
5 AC Reese , V Fradet & JS Witte (2009) Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer. J Nutrigenet Nutrigenomics 2, 149–158.
6 AR Kristal , KB Arnold , ML Neuhouser , et al. (2010) Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol 172, 566–577.
7 S Vissapragada , A Ghosh , L Ringer , et al. (2010) Dietary n-3 polyunsaturated fatty acids fail to reduce prostate tumorigenesis in the PB-ErbB-2x Pten(+/ − ) preclinical mouse model. Cell Cycle 9, 1824–1829.
8 KM Szymanski , DC Wheeler & LA Mucci (2010) Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr 92, 1223–1233.
S Hori , E Butler & J McLoughlin (2011) Prostate cancer and diet: food for thought?
10 KJ Spaccarotella , PM Kris-Etherton , WL Stone , et al. (2008) The effect of walnut intake on factors related to prostate and vascular health in older men. Nutr J 7, 13.
11 SJ Freedland & WJ Aronson (2009) Dietary intervention strategies to modulate prostate cancer risk and prognosis. Curr Opin Urol 19, 263–267.
12 JC Lloyd , JA Antonelli , TE Phillips , et al. (2010) Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model. J Urol 183, 1619–1624.
WE Hardman & G Ion (2008) Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut. Nutr Cancer
14 WE Hardman , G Ion , JA Akinsete , et al. (2011) Dietary walnut suppressed mammary gland tumorigenesis in the C(3)1 TAg mouse. Nutr Cancer 63, 960–970.
15 PA Nguewa & A Calvo (2010) Use of transgenic mice as models for prostate cancer chemoprevention. Curr Mol Med 10, 705–718.
18 LS Maguire , SM O'Sullivan , K Galvin , et al. (2004) Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. Int J Food Sci Nutr 55, 171–178.
IM Berquin , IJ Edwards & YQ Chen (2008) Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett
21 A Hsu , TM Bray , WG Helferich , et al. (2010) Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells. Exp Biol Med (Maywood) 235, 90–97.
22 DR Jacobs Jr, MD Gross & LC Tapsell (2009) Food synergy: an operational concept for understanding nutrition. Am J Clin Nutr 89, 1543S–1548S.
24 S Gupta , VM Adhami , M Subbarayan , et al. (2004) Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res 64, 3334–3343.
25 J Qi , K Nakayama , RD Cardiff , et al. (2010) Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell 18, 23–38.
26 R Xu , WH Yokoyama , D Irving , et al. (1998) Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters. Atherosclerosis 137, 29–36.
27 MB Brown & AB Forsythe (1974) Robust tests for equality of variances. J Amer Statist Assoc 69, 364–367.
28 NM Laird & JH Ware (1982) Random-effects models for longitudinal data. Biometrics 38, 963–974.
30 VM Adhami , IA Siddiqui , N Ahmad , et al. (2004) Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res 64, 8715–8722.
31 L Wang , MJ Bonorden , GX Li , et al. (2009) Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prev Res (Phila Pa) 2, 484–495.
32 L Wang , J Zhang , Y Zhang , et al. (2011) Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium. Prostate 71, 1429–1440.
SJ Freedland , J Mavropoulos , A Wang , et al. (2008) Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate
EC Cheon , MJ Strouch , MR Barron , et al. (2011) Alteration of strain background and a high omega-6 fat diet induces earlier onset of pancreatic neoplasia in EL-Kras transgenic mice. Int J Cancer
35 TE Quiner , HL Nakken , BA Mason , et al. (2011) Soy content of basal diets determines the effects of supplemental selenium in male mice. J Nutr 141, 2159–2165.
36 J Zhang , L Wang , G Li , et al. (2011) Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds. Nutr Cancer 63, 778–789.
37 TJ Key (2011) Diet, insulin-like growth factor-1 and cancer risk. Proc Nutr Soc .
38 AS Prasad , H Mukhtar , FW Beck , et al. (2010) Dietary zinc and prostate cancer in the TRAMP mouse model. J Med Food 13, 70–76.
39 M Pollak (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8, 915–928.
40 MJ Bonorden , OP Rogozina , CM Kluczny , et al. (2009) Intermittent calorie restriction delays prostate tumor detection and increases survival time in TRAMP mice. Nutr Cancer 61, 265–275.
41 JA Thomas 2nd, JA Antonelli , JC Lloyd , et al. (2010) Effect of intermittent fasting on prostate cancer tumor growth in a mouse model. Prostate Cancer Prostatic Dis 13, 350–355.
LH Chen , J Fang , Z Sun , et al. (2009) Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells. J Nutr
43 A Gualberto & M Pollak (2009) Clinical development of inhibitors of the insulin-like growth factor receptor in oncology. Curr Drug Targets 10, 923–936.
44 N Majeed , MJ Blouin , PJ Kaplan-Lefko , et al. (2005) A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model. Oncogene 24, 4736–4740.
45 M Anzo , LJ Cobb , DL Hwang , et al. (2008) Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression. Cancer Res 68, 3342–3349.
46 BW Sutherland , SE Knoblaugh , PJ Kaplan-Lefko , et al. (2008) Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium. Cancer Res 68, 3495–3504.
47 K Raina , MJ Blouin , RP Singh , et al. (2007) Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model. Cancer Res 67, 11083–11091.
49 WH Chung , TH Kim , IH Chang , et al. (2009) Relation of resistin to prostate cancer differentiation and aggressiveness. Korean J Urol 50, 540–546.
50 HJ Kim , YS Lee , EH Won , et al. (2010) Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation. BJU Int 108, E77–E83.
52 H Grosman , B Fabre , V Mesch , et al. (2010) Lipoproteins, sex hormones and inflammatory markers in association with prostate cancer. Aging Male 13, 87–92.
54 KR Solomon , K Pelton , K Boucher , et al. (2009) Ezetimibe is an inhibitor of tumor angiogenesis. Am J Pathol 174, 1017–1026.
55 G Llaverias , C Danilo , Y Wang , et al. (2010) A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. Am J Pathol 177, 3180–3191.
56 JR Krycer , I Kristiana & AJ Brown (2009) Cholesterol homeostasis in two commonly used human prostate cancer cell-lines, LNCaP and PC-3. PLoS ONE 4, e8496.
57 RM Krauss (2010) Lipoprotein subfractions and cardiovascular disease risk. Curr Opin Lipidol 21, 305–311.
58 DE Kok , JG van Roermund , KK Aben , et al. (2011) Blood lipid levels and prostate cancer risk; a cohort study. Prostate Cancer Prostatic Dis 14, 340–345.
59 C Ohlsson , S Mohan , K Sjogren , et al. (2009) The role of liver-derived insulin-like growth factor-I. Endocr Rev 30, 494–535.
60 TM Brasky , C Till , E White , et al. (2011) Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol 173, 1429–1439.
61 GP Risbridger , ID Davis , SN Birrell , et al. (2010) Breast and prostate cancer: more similar than different. Nat Rev Cancer 10, 205–212.